Cipla Ltd Performance
Open
1371.35
Traded Value (Cr)
28.33 Cr
Prev. Close
1358.8
VWAP
1365.22
Volume
11,52,636
Face Value
2
Cipla Ltd Fundamentals
Cipla Ltd F&O
Cipla Ltd Financials
Resistance and Support
₹1,385.98
PIVOT
 Resistance | |
|---|---|
| First Resistance | ₹1,396.917 |
| Second Resistance | ₹1,409.083 |
| Third Resistance | ₹1,420.017 |
 Support | |
|---|---|
| First Resistance | ₹1,373.817 |
| Second Resistance | ₹1,362.883 |
| Third Resistance | ₹1,350.717 |
| RSI | 53.175 |
| MACD | -1.738 |
| ADX | 42.249 |
| CCI | -75.191 |
Delivery and Volume
About Cipla Ltd
Cipla Limited was founded in 1935 as Chemical, Industrial, and Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied, Cipla's founder, granted the corporation royalty-free access to all of its patents and unique formulations for various pharmaceuticals and treatments. On August 17, 1935, the corporation was incorporated as a public limited company. Cipla began with its initial production facility at Bombay Central in 1936 and now has over 40 state-of-the-art manufacturing facilities worldwide, including in the United States, China, and South Africa, as well as India. Cipla started its operations with a production facility at Bombay Central in the year 1936. Over the years, it has expanded its footprint to encompass more than 40 state-of-the-art manufacturing facilities globally, located not only in India but also in countries such as the United States, China, and South Africa. Mr. Vohra has been Cipla's MD and Global CEO since September 2016. He formerly worked with Eicher Motors, PepsiCo, and Dr. Reddy's Laboratories. With a remarkable career spanning over two decades in both India and the United States, Mr. Vohra has a thorough grasp of the many components of the global pharmaceutical industry. Cipla has grown to become one of the world's most recognised brands, and several facilities and products have been introduced throughout the years. Cipla share price history is quite fascinating as the firm has made the following important business initiatives during the last several years: You can find the Cipla share price BSE & NSE today on BlinkX. From 2020 to 2023, Cipla optimised business methods, reorganised its portfolio, and increased its competitive position in key markets. Throughout the epidemic, Cipla expanded its capacities to assure universal access to quality medications. The firm has also engaged in automation and digitisation to achieve long-term efficiencies in its portfolio selection, production, supply chain, and quality operations.Cipla Ltd Share Price Today
Cipla Ltd Manufacturing Facilities
Business Segments of Cipla
Key Personnel of Cipla
Cipla Ltd Milestones
Corporate Actions of Cipla Ltd
Cipla Ltd Mergers and Acquisitions
Management Outlook of Cipla Ltd
Managing Director
Umang Vohra
Founded
1935
NSE Symbol
CIPLA
Cipla Ltd Management
| Name | Designation |
|---|---|
| Y K Hamied | Chairman (Non-Executive) |
| M K Hamied | Vice Chairman |
| S Radhakrishnan | Non-Exec & Non-Independent Dir |
| Ashok Sinha | Non-Exec. & Independent Dir. |
| Peter Mugyenyi | Non-Exec. & Independent Dir. |
| Adil Zainulbhai | Non-Exec. & Independent Dir. |
| Punita Lal | Non-Exec. & Independent Dir. |
| Samina Hamied | Executive Vice Chairperson |
| Umang Vohra | Managing Director & Global CEO |
| Rajendra Chopra | Company Sec. & Compli. Officer |
| Robert A Stewart | Independent Director |
| P R Ramesh | Independent Director |
| Mandar Purushottam Vaidya | Independent Director |